Reply  by Satran, Daniel et al.
W
t
r
b
i
i
*
G
S
M
*
H
R
4
S
E
R
1
2
3
4
5
R
W
l
M
i
o
(
C
(
i
(
d
s
p
h
i
i
t
m
o
d
i
r
c
m
a
f
w
o
a
h
b
O
a
t
p
m
a
p
D
C
*
*
9
S
M
E
R
1
2
3
4
5
6
691JACC Vol. 47, No. 3, 2006 Correspondence
February 7, 2006:683–91e suggest that CN may have had a synergetic effect with CO in
he cellular hypoxia and myocardial ischemia seen in the cases
eported by Satran et al. (1). We consider that in patients affected
y the inhalation of fire smoke, plasma lactate concentrations are as
mportant as COHb levels, especially where there is myocardial
njury.
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EPLY
e read with interest the letter of Dr. Dueñas-Laita and col-
eagues regarding our study, “Cardiovascular Manifestations of
oderate to Severe Carbon Monoxide Poisoning.” The Italian
nvestigators found 7.2% (8 of 110) of adults and 25.6% (10 of 39)
f children had elevated creatine kinase (CK) levels, whereas 1.8%
2 of 110) of adults and 12.7% (5 of 39) of children had elevated
K-MB levels in a series of patients with acute carbon monoxide
CO) poisoning (1). We found 37% of patients had myocardial
njury based on elevated cardiac enzymes and electrocardiogram
ECG) (2). We agree with the investigators that the major
ifference between our study and their own can be attributed to the
everity of CO poisoning. Our study focused on more critically ill
atients: 187 (81%) experienced loss of consciousness, 106 (46%)
ad an abnormal Glasgow Coma Scale (14), 116 (50%) were
ntubated, and 14 (6%) required blood pressure support. Another
mportant difference between the two studies is the use ofroponin, which is a more specific and sensitive indicator of
yocardial injury and would be expected to increase the percentage
f patients found to have myocardial injury. Myocardial injury
etermined by troponin has been shown to be an important
ndicator of both short- and long-term mortality (3–5). In fact, we
ecently reported preliminary data the long-term outcomes of our
ohort and found patients with myocardial injury had 31.9%
ortality compared to 16.3% in patients without myocardial injury
t a median follow-up of 6.6 years (6).
Dr. Dueñas-Laita and colleagues suggest that cyanide poisoning
rom fire exposure contributed to a higher percentage of patients
ith myocardial injury in our study. We believe this is unlikely. In
ur series of 230 patients, 42 had CO poisoning from fire exposure
nd 12 (28%) had myocardial injury. By comparison, 188 patients
ad CO poisoning from other etiologies (faulty furnace, automo-
ile exhaust, and so on) and 73 (39%) sustained myocardial injury.
ne patient exposed to fire did have confirmed cyanide poisoning,
lthough our data are otherwise limited in this area. We agree with
he researchers that testing serum lactate is reasonable in any
atient with CO exposure from fire.
Finally, the data from Dueñas-Laita and colleagues indicate
yocardial injury from even mild CO poisoning is frequent and
dds to the literature regarding the myocardial effects of CO
oisoning.
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